91 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
of this Agreement, including each of the obligations set out in the Exhibit B and C.
Full Satisfaction. The amounts payable to the Executive pursuant … to the express terms of this Agreement, if any, constitute full and final satisfaction of the Executive’s rights and entitlements in connection
8-K
EX-4.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
or otherwise) or the Holder’s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the Warrant Shares
8-K
EX-4.3
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the Preferred Investment Option Shares which
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
deducting placement agent fees and other offering expenses. The offerings are expected to close on or about October 26, 2023, subject to the satisfaction
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Company U.S. Counsel … and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) Common Shares to deliver in satisfaction
8-K
EX-4.2
tdc9ue
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.3
xt47zbhgtpwijk
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
lmcn0eqd
12 Dec 22
Changes in Registrant's Certifying Accountant
8:14pm
8-K
EX-4.1
wc529s xdxj
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.2
wp6b9nm
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.3
oc927
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.1
xql0 hsy03
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-99.1
e0ewigfmeut2wh1ye2an
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-4.1
v5uyqw9ie48owpvzfbe
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
m4u i014l3e9h4k9x
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.3
e2x2k
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm